To develop a technology that responds to the demand of consumers who want to collect SARSCoV-2 samples without pain, BIO3S, Inc. has a novel "Oral and Nasal Virus Clinical Collection(OVC) technology", for highly sensitive self-diagnosis of COVID-19. The Salivfix solution is onestep technology that does not require additional steps such as antigen extract step and RNA extraction step in an antigen rapid diagnostic tests (Ag-RDTs) and PCR analysis, respectively. BIO3S, Inc. completed clinical trial in comparing the sensitivity and specificity of collecting virus from COVID-19 patients' mouth using OVC technology, in comparison to collecting virus with conventional nasopharyngeal swab (NPS). We hope our OVC technology leads the self-testing market to diagnosis of respiratory viral infectious disease.
| Website | https://bio3s.com/ |
| Employees | 6 (2 on RocketReach) |
| Founded | 2016 |
| Industry | Biotechnology |
| Keywords | Covid19 Testing, Viral Testing, Self Testing, Molecular Diagnostics, Infectious Disease Diagnostics, Clinical Diagnostics, Sample Collection, Home Testing Kits, Rapid Diagnostics, Diagnostic Technology, At Home Diagnostics, Point Of Care Testing, Healthcare Technology, Medical Devices |
| Competitors | Roche, Thermo Fisher Scientific, Merck Group, Agilent Technologies, Illumina, MilliporeSigma, Beckman Coulter Life Sciences, Bio-Rad Laboratories, QIAGEN, PACIFIC BIOSCIENCES OF CALIF +44 more (view full list) |
Looking for a particular BIO3S employee's phone or email?
BIO3S Questions
Duwoon Kim is the CEO of BIO3S.
2 people are employed at BIO3S.
Top BIO3S Employees
Related Companies
